Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2025-12-26 @ 3:59 AM
Study NCT ID:
NCT03434418
Status:
COMPLETED
Last Update Posted:
2023-10-17
First Post:
2018-02-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations
Sponsor:
Duke University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-12
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-09
First Submit QC Date:
None
Study First Post Date:
2018-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-24
Results First Submit QC Date:
None
Results First Post Date:
2023-10-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-16
Last Update Post Date:
2023-10-17
Last Update Post Date Type:
ACTUAL